Filter Results :

Your search for Diseases returned 191 reports

Sort by


Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets

21 Jan 2015  |  Published by:  MP Advisors
Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets, approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space...

$ 2,000.00

Read More

Microbiology Testing/Clinical Microbiology Market by Product (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics), Clinical Application (Periodontal Disease, Respiratory Diseases, STD, UTI) & by Industry - Global Forecast to 2019

12 Jan 2015  |  Published by:  MarketsandMarkets
In this report, the global clinical microbiology market is segmented on the basis of products and applications. On the basis of products, the clinical microbiology market is segmented into consumables and instruments. Each of these market segments is further divided into multiple product segme...

$ 4,650.00

Read More

The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile

21 Nov 2014  |  Published by:  GlobalData
SummaryThe National Institute of Allergy and Infectious Diseases (NIAID) is a research institute. The institute develops therapies, vaccines, diagnostic tests, and other technologies to understand, treat, and prevent infectious, immunologic, and allergic diseases. Its services include research and t...

$ 250.00

Read More

Drugs for Neglected Diseases initiative - Pharmaceuticals & Healthcare - Deals and Alliances Profile

19 Nov 2014  |  Published by:  GlobalData
SummaryDrugs for Neglected Diseases initiative (DNDi) is a drug discovery company. The company develops therapeutics for the treatment of various diseases. Its products include ASAQ, ASMQ, NECT, SSG&PM and pediatric benznidazole. DNDi’s ASAQ is a fixed dose combination of artesunate and amodiaquine ...

$ 250.00

Read More

Vestibular Diseases - Pipeline Review, H2 2014

18 Nov 2014  |  Published by:  Global Markets Direct
Summary‘Vestibular Diseases - Pipeline Review, H2 2014’, provides an overview of the Vestibular Diseases’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Vestibular Diseases, complete with comparative analysis at various stages, therapeutics as...

$ 2,000.00

Read More

2014-2018 U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

12 Nov 2014  |  Published by:  VPG Market Research
This new study from Venture Planning Group contains 408 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forens...

$ 1,850.00

Read More

2014-2018 European Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing

12 Nov 2014  |  Published by:  VPG Market Research
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The repor...

$ 19,700.00

Read More

2014-2018 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

12 Nov 2014  |  Published by:  VPG Market Research
This new study from Venture Planning Group contains 430 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forens...

$ 2,750.00

Read More

2014-2018 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

12 Nov 2014  |  Published by:  VPG Market Research
This new study from Venture Planning Group contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forens...

$ 1,850.00

Read More

2014-2018 European Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

12 Nov 2014  |  Published by:  VPG Market Research
This new five-country study from Venture Planning Group contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, c...

$ 4,850.00

Read More

2014-2018 World Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

12 Nov 2014  |  Published by:  VPG Market Research
This new seven-country study from Venture Planning Group contains 570 pages, 42 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, ...

$ 8,750.00

Read More

2014-2018 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

12 Nov 2014  |  Published by:  VPG Market Research
This new study from Venture Planning Group contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well a forensi...

$ 1,850.00

Read More

2014-2018 Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

12 Nov 2014  |  Published by:  VPG Market Research
This new study from Venture Planning Group contains 410 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forens...

$ 2,450.00

Read More

2014-2018 Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

12 Nov 2014  |  Published by:  VPG Market Research
This new study from Venture Planning Group contains 402 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forens...

$ 1,850.00

Read More

2014-2018 Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

12 Nov 2014  |  Published by:  VPG Market Research
This new study from Venture Planning Group contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forens...

$ 1,850.00

Read More
Total 191 records.